Table 2 Comparison of pathological parameters among the three BMI groups.

From: Association of body mass index with clinicopathological features among patients with clear cell renal cell carcinoma treated with surgery: a retrospective study

Variable

Normal

(n = 1000)

Overweight

(n = 1096)

Obese

(n = 445)

Overweight vs. Normal

p value

Obese vs. Normal

p value

Pathological tumor diameter (mm), median (IQR)

40 (23–50)

39 (25–48)

38 (25–50)

0.31

0.21

pT stage, n (%)

   

0.28

0.23

 pT1a

640 (64.0%)

696 (63.5%)

284 (63.8%)

  

 pT1b

219 (21.9%)

272 (24.8%)

114 (25.6%)

  

 pT2a

35 (3.5%)

31 (2.8%)

12 (2.7%)

  

 pT2b

14 (1.4%)

9 (0.8%)

7 (1.6%)

  

 ≥pT3

92 (9.2%)

88 (8.0%)

28 (6.3%)

  

 T3a

65

68

25

  

 T3b

13

13

3

  

 T3c

5

1

0

  

 T4

9

6

0

  

Nuclear grade, n (%)

   

0.12

<0.001

 1

87 (8.7%)

118 (10.8%)

80 (18.0%)

  

 2

781 (78.1%)

864 (78.8%)

315 (70.8%)

  

 3

99 (9.9%)

84 (7.7%)

46 (10.3%)

  

 4

33 (3.3%)

30 (2.7%)

4 (0.9%)

  

Renal capsular invasion, n (%)

73 (7.3%)

71 (6.5%)

15 (3.4%)

0.49

<0.01

Perirenal fat/renal sinus fat invasion, n (%)

54 (5.4%)

59 (5.4%)

13 (2.9%)

1.00

<0.05

Vein cancerous embolus, n (%)

57 (5.7%)

46 (4.2%)

12 (2.7%)

0.11

<0.05

Microscopic/Segmental renal vein invasion

52

37

11

  

Renal vein cancerous embolus

8

15

3

  

Inferior vena cava cancerous embolus

16

11

3